AbouLaila Mahmoud, Batadoj Davasorin, Salama Akram, Munkhjargal Tserendorj, Ichikawa-Seki Madoka, A Terkawi Mohammad, Yokoyama Naoaki, Igarashi Ikuo
National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-cho, Obihiro, Hokkaido 080-8555, Japan; Department of Parasitology, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Minoufiya, Egypt.
National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-cho, Obihiro, Hokkaido 080-8555, Japan.
Vet Parasitol. 2014 Aug 29;204(3-4):104-10. doi: 10.1016/j.vetpar.2014.05.023. Epub 2014 May 23.
Miltefosine, a membrane-active synthetic ether-lipid analogue, has antiproliferative and antiparasitic effects. In this study, the inhibitory effects of miltefosine were evaluated against three Babesia species and Theileria equi in vitro and against Babesia microti in mice. The drug showed significant growth inhibition from an initial parasitemia of 1% for Babesia bovis, Babesia bigemina, Babesia caballi, and T. equi with IC50 values of 25, 10.2, 10.4, and 99 μM, respectively. Complete inhibition was observed at 200 μM of miltefosine on the third day of culture for the three Babesia species and 400 μM on the fourth day for T. equi. Reverse-transcription PCR (RT-PCR) showed that miltefosine inhibited the transcription of choline-phosphate cytidylyltransferase in B. bovis. Miltefosine at a dose rate of 30 mg/kg resulted in a 71.7% inhibition of B. microti growth in BALB/c mice. Miltefosine might be used for drug therapy in babesiosis.
米替福新是一种具有膜活性的合成醚脂类似物,具有抗增殖和抗寄生虫作用。在本研究中,评估了米替福新对三种巴贝斯虫属物种和马泰勒虫的体外抑制作用,以及对小鼠微小巴贝斯虫的抑制作用。该药物对牛巴贝斯虫、双芽巴贝斯虫、马巴贝斯虫和马泰勒虫从初始1%的寄生虫血症起就表现出显著的生长抑制,其半数抑制浓度(IC50)值分别为25、10.2、10.4和99 μM。在培养的第三天,200 μM米替福新对三种巴贝斯虫属物种实现了完全抑制,对马泰勒虫在第四天400 μM时实现了完全抑制。逆转录聚合酶链反应(RT-PCR)表明,米替福新抑制了牛巴贝斯虫中胆碱磷酸胞苷转移酶的转录。以30 mg/kg的剂量率给药时,米替福新对BALB/c小鼠体内微小巴贝斯虫的生长抑制率达71.7%。米替福新可能用于巴贝斯虫病的药物治疗。